Aus­tralian ra­dio­phar­ma Telix launch­es bid for Nas­daq list­ing

Last year
Financing

Eras­ca re­vamps pipeline, lay­ing off staff as it li­cens­es can­cer drugs from Chi­na and nabs $160M

Last year
Deals
R&D

Bay­er de­tails da­ta from two Phase 3 tri­al wins for menopause symp­tom drug

Last year
R&D

Jim Burns re­unites with Gen­zyme col­league at En­so­ma; Lil­ly ex­ec to re­tire af­ter 27 years

Last year
People
Peer Review

FDA ap­proves Am­gen’s T cell en­gager in ag­gres­sive form of lung can­cer

Last year
Pharma
FDA+

GSK plans to sell off re­main­ing stake in con­sumer spin­out Ha­le­on

Last year
Deals
Pharma

Phar­ma is re­think­ing how it in­ter­acts with pa­tients af­ter Eli Lil­ly ripped up the play­book

Last year
Pharma
Health Tech

Roche was in 'ad­vanced' talks to out-li­cense its An­gel­man syn­drome drug, but po­ten­tial part­ner with­drew

Last year
Deals
R&D

Bain, At­las, RTW back new biotech de­vel­op­ing obe­si­ty drugs with $400M

Last year
Startups
China

House pan­el ad­vances bills tar­get­ing rare dis­ease, pri­or­i­ty re­view vouch­ers

Last year
Pharma
FDA+

Bris­tol My­er­s' CAR-T ther­a­py Breyanzi adds fol­lic­u­lar lym­phoma to list of ap­provals

Last year
Pharma
Cell/Gene Tx

Bio­gen CEO Viehbach­er un­daunt­ed by Lil­ly's im­pend­ing Alzheimer's ther­a­py, say­ing it will ‘ex­pand’ mar­ket

Last year
R&D

WuXi Bi­o­log­ics paus­es Mass­a­chu­setts build; No­vo Hold­ings nabs ma­jor­i­ty stake in phar­ma tools firm  

Last year
Manufacturing

Pfiz­er, Arv­inas’ breast can­cer drug com­bo keeps mo­men­tum af­ter Phase 1b up­date

Last year
R&D

Bio­gen and Io­n­is aban­don ALS drug af­ter dis­ap­point­ing ear­ly-stage tri­al

Last year
R&D

Monte Rosa’s $100M of­fer­ing; Alex­ion to hand back pre­clin­i­cal pro­gram to Zealand Phar­ma

Last year
News Briefing

As­traZeneca's suc­ces­sor to Covid block­buster Evusheld suc­ceeds in Phase 3 tri­al

Last year
R&D
Coronavirus

J&J makes small I&I ac­qui­si­tion to en­ter com­pet­i­tive IL-13, TSLP are­na

Last year
Deals
R&D

Lil­ly touts topline late-phase da­ta for once-week­ly in­sulin in race to en­ter US mar­ket

Last year
R&D

GSK, UK gov­ern­ment bud­get £130M to fight glob­al an­timi­cro­bial re­sis­tance

Last year
Financing
Pharma

Ex­clu­sive: Gas­tro­pare­sis biotech Cin­Dome se­cures $40M for path to piv­otal tri­al

Last year
Financing
R&D

Roche teas­es 'en­cour­ag­ing' Phase 1 da­ta for weight loss drug from $2.7B Car­mot buy­out

Last year
R&D

Aim­ing to de­cen­tral­ize CAR-T man­u­fac­tur­ing, Gala­pa­gos part­ners with largest US blood sup­ply net­work

Last year
Cell/Gene Tx
Manufacturing

BeiGene looks at new part­ner­ships, with a full can­cer pipeline and grow­ing foot­print

Last year
Deals
China
First page Previous page 156157158159160161162 Next page Last page
A service from the Financial Times